|
7WKU
Structure of PDCoV Mpro in complex with an inhibitor
Deposited 2022-01-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
2509–2815(307 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
BATCH MODE;291 K;0.1M sodium citrate (pH 5.1), 4% (w/v) polyethylene glycol 6000
|
Resolution 2.60 Å
R-free 0.241
|
|
7WKU
Structure of PDCoV Mpro in complex with an inhibitor
Deposited 2022-01-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
2509–2815(307 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
BATCH MODE;291 K;0.1M sodium citrate (pH 5.1), 4% (w/v) polyethylene glycol 6000
|
Resolution 2.60 Å
R-free 0.241
|
|
7WKU
Structure of PDCoV Mpro in complex with an inhibitor
Deposited 2022-01-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
2509–2815(307 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
BATCH MODE;291 K;0.1M sodium citrate (pH 5.1), 4% (w/v) polyethylene glycol 6000
|
Resolution 2.60 Å
R-free 0.241
|
|
7WKU
Structure of PDCoV Mpro in complex with an inhibitor
Deposited 2022-01-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
2509–2815(307 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
BATCH MODE;291 K;0.1M sodium citrate (pH 5.1), 4% (w/v) polyethylene glycol 6000
|
Resolution 2.60 Å
R-free 0.241
|
|
7WKU
Structure of PDCoV Mpro in complex with an inhibitor
Deposited 2022-01-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain E
2509–2815(307 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
BATCH MODE;291 K;0.1M sodium citrate (pH 5.1), 4% (w/v) polyethylene glycol 6000
|
Resolution 2.60 Å
R-free 0.241
|
|
7WKU
Structure of PDCoV Mpro in complex with an inhibitor
Deposited 2022-01-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 6
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain F
2509–2815(307 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
BATCH MODE;291 K;0.1M sodium citrate (pH 5.1), 4% (w/v) polyethylene glycol 6000
|
Resolution 2.60 Å
R-free 0.241
|
|
9UOS
Crystal structure of PDCoV 3CL protease (3CLpro) in complex with compound 8
Deposited 2025-04-26
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
2509–2809(301 aa)
Chain D
2509–2809(301 aa)
|
Not recorded
|
A1EPZ (2~{S})-2-[[(2~{S})-3,3-dimethyl-2-[2,2,2-tris(fluoranyl)ethanoylamino]butanoyl]amino]-4-methyl-~{N}-[(2~{S})-1-oxidanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]pentanamide × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.5-2% PEG6000, 100 mM sodium citrate, pH 4.6-5.25
|
Resolution 2.73 Å
R-free 0.260
|
|
9UOS
Crystal structure of PDCoV 3CL protease (3CLpro) in complex with compound 8
Deposited 2025-04-26
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain B
2509–2809(301 aa)
Chain E
2509–2809(301 aa)
|
Not recorded
|
A1EPZ (2~{S})-2-[[(2~{S})-3,3-dimethyl-2-[2,2,2-tris(fluoranyl)ethanoylamino]butanoyl]amino]-4-methyl-~{N}-[(2~{S})-1-oxidanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]pentanamide × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.5-2% PEG6000, 100 mM sodium citrate, pH 4.6-5.25
|
Resolution 2.73 Å
R-free 0.260
|
|
9UOS
Crystal structure of PDCoV 3CL protease (3CLpro) in complex with compound 8
Deposited 2025-04-26
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 3
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain C
2509–2809(301 aa)
Chain F
2509–2809(301 aa)
|
Not recorded
|
A1EPZ (2~{S})-2-[[(2~{S})-3,3-dimethyl-2-[2,2,2-tris(fluoranyl)ethanoylamino]butanoyl]amino]-4-methyl-~{N}-[(2~{S})-1-oxidanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]pentanamide × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.5-2% PEG6000, 100 mM sodium citrate, pH 4.6-5.25
|
Resolution 2.73 Å
R-free 0.260
|
|
9X7D
Crystal structure of PDCoV 3CL protease (3CLpro) in complex with nirmatrelvir
Deposited 2025-10-16
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
2509–2809(301 aa)
Chain E
2509–2809(301 aa)
|
Not recorded
|
4WI (1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.5-2% PEG6000, 100 mM sodium citrate, pH 4.6-5.25
|
Resolution 2.28 Å
R-free 0.249
|
|
9X7D
Crystal structure of PDCoV 3CL protease (3CLpro) in complex with nirmatrelvir
Deposited 2025-10-16
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain B
2509–2809(301 aa)
Chain D
2509–2809(301 aa)
|
Not recorded
|
4WI (1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.5-2% PEG6000, 100 mM sodium citrate, pH 4.6-5.25
|
Resolution 2.28 Å
R-free 0.249
|
|
9X7D
Crystal structure of PDCoV 3CL protease (3CLpro) in complex with nirmatrelvir
Deposited 2025-10-16
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 3
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain C
2509–2809(301 aa)
Chain F
2509–2809(301 aa)
|
Not recorded
|
4WI (1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.5-2% PEG6000, 100 mM sodium citrate, pH 4.6-5.25
|
Resolution 2.28 Å
R-free 0.249
|
|
9X7F
Crystal structure of PDCoV 3CL protease (3CLpro) in complex with compound 1
Deposited 2025-10-16
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
2509–2809(301 aa)
Chain B
2509–2809(301 aa)
|
Not recorded
|
A1D7G (2~{S})-~{N}-[(2~{S})-1-azanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]-2-[[(2~{S})-3,3-dimethyl-2-[2,2,2-tris(fluoranyl)ethanoylamino]butanoyl]amino]-4-methyl-pentanamide × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.5-2% PEG6000, 100 mM sodium citrate, pH 4.6-5.25
|
Resolution 2.64 Å
R-free 0.244
|
|
9X7F
Crystal structure of PDCoV 3CL protease (3CLpro) in complex with compound 1
Deposited 2025-10-16
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain C
2509–2809(301 aa)
Chain D
2509–2809(301 aa)
|
Not recorded
|
A1D7G (2~{S})-~{N}-[(2~{S})-1-azanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]-2-[[(2~{S})-3,3-dimethyl-2-[2,2,2-tris(fluoranyl)ethanoylamino]butanoyl]amino]-4-methyl-pentanamide × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.5-2% PEG6000, 100 mM sodium citrate, pH 4.6-5.25
|
Resolution 2.64 Å
R-free 0.244
|
|
9X7F
Crystal structure of PDCoV 3CL protease (3CLpro) in complex with compound 1
Deposited 2025-10-16
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 3
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain E
2509–2809(301 aa)
Chain F
2509–2809(301 aa)
|
Not recorded
|
A1D7G (2~{S})-~{N}-[(2~{S})-1-azanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]-2-[[(2~{S})-3,3-dimethyl-2-[2,2,2-tris(fluoranyl)ethanoylamino]butanoyl]amino]-4-methyl-pentanamide × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.5-2% PEG6000, 100 mM sodium citrate, pH 4.6-5.25
|
Resolution 2.64 Å
R-free 0.244
|
|
9X7G
Crystal structure of PDCoV 3CL protease (3CLpro) in complex with compound 3
Deposited 2025-10-16
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
2509–2809(301 aa)
Chain B
2509–2809(301 aa)
|
Not recorded
|
A1D7N (1~{R},2~{S},5~{S})-~{N}-[(2~{S})-1-azanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]-3-[(2~{S})-3,3-dimethyl-2-(methylsulfonylamino)butanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.5-2% PEG6000, 100 mM sodium citrate, pH 4.6-5.25
|
Resolution 2.57 Å
R-free 0.258
|
|
9X7G
Crystal structure of PDCoV 3CL protease (3CLpro) in complex with compound 3
Deposited 2025-10-16
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain C
2509–2809(301 aa)
Chain D
2509–2809(301 aa)
|
Not recorded
|
A1D7N (1~{R},2~{S},5~{S})-~{N}-[(2~{S})-1-azanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]-3-[(2~{S})-3,3-dimethyl-2-(methylsulfonylamino)butanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.5-2% PEG6000, 100 mM sodium citrate, pH 4.6-5.25
|
Resolution 2.57 Å
R-free 0.258
|
|
9X7G
Crystal structure of PDCoV 3CL protease (3CLpro) in complex with compound 3
Deposited 2025-10-16
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 3
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain E
2509–2809(301 aa)
Chain F
2509–2809(301 aa)
|
Not recorded
|
A1D7N (1~{R},2~{S},5~{S})-~{N}-[(2~{S})-1-azanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]-3-[(2~{S})-3,3-dimethyl-2-(methylsulfonylamino)butanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.5-2% PEG6000, 100 mM sodium citrate, pH 4.6-5.25
|
Resolution 2.57 Å
R-free 0.258
|